These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2196148)

  • 21. Pharmacokinetics of ciprofloxacin. 2nd communication: distribution to and elimination from tissues and organs following single or repeated administration of [14C]ciprofloxacin in albino rats.
    Siefert HM; Maruhn D; Scholl H
    Arzneimittelforschung; 1986 Oct; 36(10):1503-10. PubMed ID: 3101707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Penetration of ciprofloxacin into gynecological tissues following oral and intravenous administration.
    Goormans E; Dalhoff A; Kazzaz B; Branolte J
    Chemotherapy; 1986; 32(1):7-17. PubMed ID: 2936582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition kinetics of ciprofloxacin in lactating goats.
    el-Banna HA; Abo el-Sooud K
    Dtsch Tierarztl Wochenschr; 1998 Jan; 105(1):35-8. PubMed ID: 9499632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of difloxacin and its concentration in body fluids and endometrial tissues of mares after repeated intragastric administration.
    Adams AR; Haines GR; Brown MP; Gronwall R; Merritt K
    Can J Vet Res; 2005 Jul; 69(3):229-35. PubMed ID: 16187554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and residues of ciprofloxacin and its metabolites in broiler chickens.
    Anadón A; Martínez-Larrañaga MR; Iturbe J; Martínez MA; Díaz MJ; Frejo MT; Martínez M
    Res Vet Sci; 2001 Oct; 71(2):101-9. PubMed ID: 11883887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative pharmacokinetics and safety of ciprofloxacin 400 mg i.v. thrice daily versus 750 mg po twice daily.
    Shah A; Lettieri J; Kaiser L; Echols R; Heller AH
    J Antimicrob Chemother; 1994 Apr; 33(4):795-801. PubMed ID: 8056698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative pharmacokinetic disposition of fluoroquinolones in the lung.
    Wise R; Baldwin DR; Andrews JM; Honeybourne D
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():65-71. PubMed ID: 1664831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients.
    Müller M; Brunner M; Hollenstein U; Joukhadar C; Schmid R; Minar E; Ehringer H; Eichler HG
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2056-8. PubMed ID: 10428936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Penetration of ciprofloxacin into gynecologic tissues.
    Dalhoff A; Weuta H
    Am J Med; 1987 Apr; 82(4A):133-8. PubMed ID: 3555027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Penetration of fleroxacin and ciprofloxacin into skin blister fluid: a comparative study.
    Lubowski TJ; Nightingale C; Sweeney K; Quintiliani R; Zhi J
    Antimicrob Agents Chemother; 1992 Mar; 36(3):651-5. PubMed ID: 1622179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciprofloxacin concentrations in tonsils following single or multiple administrations.
    Falser N; Dalhoff A; Weuta H
    Infection; 1988; 16 Suppl 1():S14-8. PubMed ID: 3372028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung tissue concentrations of ciprofloxacin following intravenous administration in patients.
    Forst H; Ruckdeschel G; Unertl K; Dieterich HJ; Ehret W; Sunder-Plassmann L
    Arzneimittelforschung; 1989 May; 39(5):618-9. PubMed ID: 2757681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Penetration of ciprofloxacin into human cerebrospinal fluid in patients with inflamed and non-inflamed meninges.
    Gogos CA; Maraziotis TG; Papadakis N; Beermann D; Siamplis DK; Bassaris HP
    Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):511-4. PubMed ID: 1915388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soft tissue concentrations of ciprofloxacin in obese and lean subjects following weight-adjusted dosing.
    Hollenstein UM; Brunner M; Schmid R; Müller M
    Int J Obes Relat Metab Disord; 2001 Mar; 25(3):354-8. PubMed ID: 11319632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacokinetics of ciprofloxacin in young healthy volunteers].
    Liang D; Qin Y; Xu N; Zhang H; Li J
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Sep; 24(3):306-8. PubMed ID: 8288206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of the concentration of ciprofloxacin in prostate tissue following administration of a single, 1000 mg, extended-release dose.
    Lugg J; Lettieri J; Stass H; Agarwal V
    J Chemother; 2008 Apr; 20(2):213-8. PubMed ID: 18467248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of chloramphenicol in some tissues and extravascular fluids of dogs after oral administration.
    Watson AD; McDonald PJ
    Am J Vet Res; 1976 May; 37(5):557-9. PubMed ID: 1275341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
    Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic disposition of sequential intravenous/oral ciprofloxacin in pediatric cystic fibrosis patients with acute pulmonary exacerbation.
    Rubio TT; Miles MV; Lettieri JT; Kuhn RJ; Echols RM; Church DA
    Pediatr Infect Dis J; 1997 Jan; 16(1):112-7; discussion 123-6. PubMed ID: 9002120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review.
    Sorgel F; Naber KG; Kinzig M; Mahr G; Muth P
    Am J Med; 1991 Dec; 91(6A):51S-66S. PubMed ID: 1662896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.